Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb5d44e15e402abbf25c43eb3f714e9c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
filingDate |
2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1643e42e6c7d2ce1417843cb53245421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48304d448557f7e004d0cb29b70f2438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e6b98e14114b87469dce839207e10ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe623bdd7b8a227a3217a2f7f21c97e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7af9e98b0551142c2dd3ababeb71da3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d64b31a66415d3c5dfd4dc14eba5815 |
publicationDate |
2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10968255-B2 |
titleOfInvention |
Compositions comprising HIV envelopes to induce CH235 lineage antibodies |
abstract |
In certain aspects the invention provides HIV-1 immunogens, including HIV-1 envelope selections from individual CH505, and methods for swarm immunizations using combinations of HIV-1 envelopes. |
priorityDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |